NCT04391491View on ClinicalTrials.gov

Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

December 1, 2022

Study Completion Date

February 1, 2023

Conditions
Heart Failure With Preserved Ejection FractionMicrovascular AnginaPulmonary HypertensionHeart Failure With Reduced Ejection Fraction
Interventions
DIAGNOSTIC_TEST

Neuregulin-1β level in plasma

Peripheral blood will be collected after randomization (plus or minus 3 days), the plasma will be assayed for neuregulin-1b, biomarkers of inflammation and fibrosis, NTproBNP

Trial Locations (1)

119415

Anastasia Shchendrygina, Moscow

All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

collaborator

University of Basel

OTHER

lead

I.M. Sechenov First Moscow State Medical University

OTHER

NCT04391491 - Neuregulin-1 in Patient With Different Forms of Cardiovascular Diseases: a Pilot Study | Biotech Hunter | Biotech Hunter